Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walker, A. E.
Right arrow Articles by Weinfeld, F. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, A. E.
Right arrow Articles by Weinfeld, F. D.
NEUROLOGY 1985;35:219
© 1985 American Academy of Neurology

Epidemiology of brain tumors

The national survey of intracranial neoplasms

A. Earl Walker, MD, Morton Robins, MSPH and Frederic D. Weinfeld, EdD

Department of Neurosurgery (Dr. Walker), University of New Mexico School of Medicine, Albuquerque, NM; Westat Research (Mr. Robins), Rockville; and Section of Surveys and Demographic Studies (Dr. Weinfeld), National Institute of Neurological and Communicative Disorders and Stroke, Bethesda, MD.

A national survey, based on a probability sample of patients admitted to short-term hospitals in the United States during 1973 to 1974 with a discharge diagnosis of an intracranial neoplasm, was conducted in 157 hospitals. The annual incidence was estimated at 17,000 for primary intracranial neoplasms and 17,400 for secondary intracranial neoplasms—8.2 and 8.3 per 100,000 US population, respectively. Rates of primary intracranial neoplasms increased steadily with advancing age. The age-adjusted rates were higher among men than among women (8.5 versus 7.9 per 100,000). However, although men were more susceptible to gliomas and neuronomas, incidence rates for meningiomas and pituitary adenomas were higher among women.

Address correspondence and reprint requests to Dr. Weinfeld, Chief, Section on Surveys and Demographic Studies, National Institute of Neurological and Communicative Disorders and Stroke, 7550 Wisconsin Avenue, Bethesda, MD 20205.

Supported by the National Institute of Neurological and Communicative Disorders and Stroke under Contract No. NO-1-NS-4–2336 with Westat Research, who condurted the national survey.

Accepted for publication June 8, 1984.




This article has been cited by other articles:


Home page
Cancer Res.Home page
F. Pisati, M. Belicchi, F. Acerbi, C. Marchesi, C. Giussani, M. Gavina, S. Javerzat, M. Hagedorn, G. Carrabba, V. Lucini, et al.
Effect of Human Skin-Derived Stem Cells on Vessel Architecture, Tumor Growth, and Tumor Invasion in Brain Tumor Animal Models
Cancer Res., April 1, 2007; 67(7): 3054 - 3063.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. Akabani, D. A. Reardon, R. E. Coleman, T. Z. Wong, S. D. Metzler, J. E. Bowsher, D. P. Barboriak, J. M. Provenzale, K. L. Greer, D. DeLong, et al.
Dosimetry and Radiographic Analysis of 131I-Labeled Anti-Tenascin 81C6 Murine Monoclonal Antibody in Newly Diagnosed Patients with Malignant Gliomas: A Phase II Study
J. Nucl. Med., June 1, 2005; 46(6): 1042 - 1051.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Nakamizo, F. Marini, T. Amano, A. Khan, M. Studeny, J. Gumin, J. Chen, S. Hentschel, G. Vecil, J. Dembinski, et al.
Human Bone Marrow-Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Cancer Res., April 15, 2005; 65(8): 3307 - 3318.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Kirsch, P. Weigel, T. Pinzer, R. S. Carroll, P. McL. Black, H.-K. Schackert, and G. Schackert
Therapy of Hematogenous Melanoma Brain Metastases with Endostatin
Clin. Cancer Res., February 1, 2005; 11(3): 1259 - 1267.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. S. Barnholtz-Sloan, A. E. Sloan, F. G. Davis, F. D. Vigneau, P. Lai, and R. E. Sawaya
Incidence Proportions of Brain Metastases in Patients Diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System
J. Clin. Oncol., July 15, 2004; 22(14): 2865 - 2872.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. F. Lang, J. M. Bruner, G. N. Fuller, K. Aldape, M. D. Prados, S. Chang, M. S. Berger, M. W. McDermott, S. M. Kunwar, L. R. Junck, et al.
Phase I Trial of Adenovirus-Mediated p53 Gene Therapy for Recurrent Glioma: Biological and Clinical Results
J. Clin. Oncol., July 1, 2003; 21(13): 2508 - 2518.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
F. F. Lang, M. R. Gilbert, V. K. Puduvalli, J. Weinberg, V. A. Levin, W.K. A. Yung, R. Sawaya, G. N. Fuller, and C. A. Conrad
Toward better early-phase brain tumor clinical trials: A reappraisal of current methods and proposals for future strategies
Neuro-oncol, October 1, 2002; 4(4): 268 - 277.
[Abstract] [PDF]


Home page
Neuro Oncol DukeHome page
B. J. McCarthy, T. Surawicz, J. M. Bruner, C. Kruchko, and F. Davis
Consensus Conference on Brain Tumor Definition for Registration
Neuro-oncol, April 1, 2002; 4(2): 134 - 145.
[Abstract] [PDF]


Home page
Cancer Res.Home page
T. Shono, P. J. Tofilon, T. S. Schaefer, D. Parikh, T.-J. Liu, and F. F. Lang
Apoptosis Induced by Adenovirus-mediated p53 Gene Transfer in Human Glioma Correlates with Site-specific Phosphorylation
Cancer Res., February 1, 2002; 62(4): 1069 - 1076.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. Bonnette, P. Puyo, C. Gabriel, R. Giudicelli, J.-F. Regnard, M. Riquet, and P.-Y. Brichon
Surgical Management of Non-small Cell Lung Cancer With Synchronous Brain Metastases
Chest, May 1, 2001; 119(5): 1469 - 1475.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. W. Rand, R. J. Kreitman, N. Patronas, F. Varricchio, I. Pastan, and R. K. Puri
Intratumoral Administration of Recombinant Circularly Permuted Interleukin-4-Pseudomonas Exotoxin in Patients with High-Grade Glioma
Clin. Cancer Res., June 1, 2000; 6(6): 2157 - 2165.
[Abstract] [Full Text]


Home page
BrainHome page
B. K. MacDonald, O. C. Cockerell, J. W. A. S. Sander, and S. D. Shorvon
The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK
Brain, April 1, 2000; 123(4): 665 - 676.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. R. Graf, M. R. Jadus, J. C. Hiserodt, H. T. Wepsic, and G. A. Granger
Development of Systemic Immunity to Glioblastoma Multiforme Using Tumor Cells Genetically Engineered to Express the Membrane-Associated Isoform of Macrophage Colony-Stimulating Factor
J. Immunol., November 15, 1999; 163(10): 5544 - 5551.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
T. S. Surawicz, B. J. McCarthy, V. Kupelian, P. J. Jukich, J. M. Bruner, F. G. Davis, and the collaborating registries of the Central Brain
Descriptive epidemiology of primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994
Neuro-oncol, January 1, 1999; 1(1): 14 - 25.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
M. P. Merchut
Brain Metastases From Undiagnosed Systemic Neoplasms
Arch Intern Med, May 1, 1989; 149(5): 1076 - 1080.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by AAN Enterprises, Inc.